BioSpace News Archive

BioMidwest

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

Acura Pharmaceuticals, Inc. announced an amendment to its License, Development and Commercialization Agreement regarding Acura’s LIMITx™ LTX-03 product candidate with Abuse Deterrent Pharmaceuticals, LLC to extend the FDA Acceptance Date for LTX-03 to December 31, 2022.

March 1, 2022
·
6 min read
Business

Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results

Xilio Therapeutics, Inc. today announced pipeline and business progress and reported financial results for the fourth quarter and full year ended December 31, 2021.

March 1, 2022
·
9 min read
Business

Cerevel Therapeutics Provides Update on Pipeline Progress along with Fourth Quarter and Full Year 2021 Financial Results

Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided key business updates.

March 1, 2022
·
14 min read
Business

Zepp Health Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 17, 2022

Zepp Health Corp. today announced that it will report its fourth quarter and full year 2021 unaudited financial results.

March 1, 2022
·
2 min read
Business

Caris’ Precision Oncology Alliance Welcomes Tampa General Hospital Cancer Institute

Caris Life Sciences ® announced today that Tampa General Hospital Cancer Institute (TGH Cancer Institute) has joined Caris’ Precision Oncology Alliance™ (POA).

March 1, 2022
·
8 min read
Drug Development

Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints

Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints.

March 1, 2022
·
10 min read
Pharm Country

PLx Pharma Inc. to Present at Oppenheimer & Co’s 32nd Annual Healthcare Conference on March 15, 2022

PLx Pharma Inc. today announced that Natasha Giordano, President and CEO of PLx Pharma Inc. and Rita O’Connor, Chief Financial Officer & Head of Manufacturing & Supply Chain, will present on March 15, 2022, at Oppenheimer & Co’s 32nd Annual Healthcare Conference, which will be a virtual event this year.

March 1, 2022
·
2 min read
Business

Meghan Rivera Appointed US Managing Director, Organon

Organon today announced the appointment of Meghan Rivera as US Managing Director.

March 1, 2022
·
2 min read
Genetown

EyePoint Pharmaceuticals to Participate in Fireside Chat at the Cowen 42nd Annual Health Care Conference

EyePoint Pharmaceuticals, Inc. announced that Nancy Lurker, Chief Executive Officer of EyePoint Pharmaceuticals, will participate in a fireside chat at the Cowen 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 10:30 a.m. ET.

March 1, 2022
·
1 min read
Genetown

iTeos to Present at the Cowen 42nd Annual Health Care Conference

iTeos Therapeutics, Inc. today announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the Cowen 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 12:50 p.m. ET.

March 1, 2022
·
2 min read